

Novo Nordisk has lowered prices for its obesity drug Wegovy by 50% in China, ahead of generic competition.
You can purchase shares of INNOVENT BIOLOGICS INC by Innovent Biologics Inc. (OTCPK:IVBXF) through any online brokerage.
There are no as such competitors for INNOVENT BIOLOGICS INC by Innovent Biologics Inc..
There is no analysis for INNOVENT BIOLOGICS INC by Innovent Biologics Inc. to provide a consensus price target.
The stock price for INNOVENT BIOLOGICS INC by Innovent Biologics Inc. (OTCPK: IVBXF) is $11.112 last updated October 28, 2026 at 3:40 PM EDT.
There are no upcoming dividends for INNOVENT BIOLOGICS INC by Innovent Biologics Inc..
INNOVENT BIOLOGICS INC by Innovent Biologics Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for INNOVENT BIOLOGICS INC by Innovent Biologics Inc..
INNOVENT BIOLOGICS INC by Innovent Biologics Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Innovent Biologics is one of the leading biotechnology companies in China. Listed on the Hong Kong Stock Exchange in 2018, Innovent has 12 commercialized oncology products and four commercialized nononcology products as of January 2026, and 34 drugs...